Related references
Note: Only part of the references are listed.Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
Ming Yi et al.
MOLECULAR CANCER (2022)
Combining mannose receptor mediated nanovaccines and gene regulated PD-L1 blockade for boosting cancer immunotherapy
Jie Chen et al.
BIOACTIVE MATERIALS (2022)
In situ phase transitional polymeric vaccines for improved immunotherapy
Jie Wang et al.
NATIONAL SCIENCE REVIEW (2022)
Phenylboronic Acid Modification Augments the Lysosome Escape and Antitumor Efficacy of a Cylindrical Polymer Brush-Based Prodrug
Ruonan Wang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers
David H. Peng et al.
NATURE COMMUNICATIONS (2021)
Photothermal-Chemotherapy Enhancing Tumor Immunotherapy by Multifunctional Metal-Organic Framework Based Drug Delivery System
Weidong Ni et al.
NANO LETTERS (2021)
Double enhancement of immunogenic cell death and antigen presentation for cancer immunotherapy
Xiang Xiong et al.
NANO TODAY (2021)
Targeting dual gene delivery nanoparticles overcomes immune checkpoint blockade induced adaptive resistance and regulates tumor microenvironment for improved tumor immunotherapy
Yuanji Feng et al.
NANO TODAY (2021)
Combination of epigenetic regulation with gene therapy-mediated immune checkpoint blockade induces anti-tumour effects and immune response in vivo
Huapan Fang et al.
NATURE COMMUNICATIONS (2021)
NK cells for cancer immunotherapy
Noriko Shimasaki et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Biological Functions and Analytical Strategies of Sialic Acids in Tumor
Xiaoman Zhou et al.
CELLS (2020)
Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape
Constance J. Martin et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
TGFβ suppresses CD8+ T cell expression of CXCR3 and tumor trafficking
Andrew J. Gunderson et al.
NATURE COMMUNICATIONS (2020)
Polymer nanomedicines
Jindrich Kopecek et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes
Floris Dammeijer et al.
CANCER CELL (2020)
TGF-β suppresses type 2 immunity to cancer
Ming Liu et al.
NATURE (2020)
An immune cocktail therapy to realize multiple boosting of the cancer-immunity cycle by combination of drug/gene delivery nanoparticles
Jiayan Wu et al.
SCIENCE ADVANCES (2020)
Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade
Eduardo Bonavita et al.
IMMUNITY (2020)
A ROS-Responsive Aspirin Polymeric Prodrug for Modulation of Tumor Microenvironment and Cancer Immunotherapy
Sheng Ma et al.
CCS CHEMISTRY (2020)
Nanoenabled Modulation of Acidic Tumor Microenvironment Reverses Anergy of Infiltrating T Cells and Potentiates Anti-PD-1 Therapy
Yu-Xue Zhang et al.
NANO LETTERS (2019)
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
Leonie Voorwerk et al.
NATURE MEDICINE (2019)
Mechanisms of immunotherapy resistance: lessons from glioblastoma
Christopher M. Jackson et al.
NATURE IMMUNOLOGY (2019)
Enzyme-activatable polymer-drug conjugate augments tumour penetration and treatment efficacy
Quan Zhou et al.
NATURE NANOTECHNOLOGY (2019)
Differences in Tumor Microenvironment Dictate T Helper Lineage Polarization and Response to Immune Checkpoint Therapy
Shiping Jiao et al.
CELL (2019)
Back to the Future: Effector Fate during T Cell Exhaustion
Veit R. Buchholz et al.
IMMUNITY (2019)
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody
Danbee Ha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade
Fangyuan Zhou et al.
ADVANCED MATERIALS (2019)
PD-1 Blockade Cellular Vesicles for Cancer Immunotherapy
Xudong Zhang et al.
ADVANCED MATERIALS (2018)
A Novel TGFβ Trap Blocks Chemotherapeutics-Induced TGFβ1 Signaling and Enhances Their Anticancer Activity in Gynecologic Cancers
Haiyan Zhu et al.
CLINICAL CANCER RESEARCH (2018)
TGF-β Inhibition and Immunotherapy: Checkmate
Karuna Ganesh et al.
IMMUNITY (2018)
High Drug Loading and Sub-Quantitative Loading Efficiency of Polymeric Micelles Driven by Donor-Receptor Coordination Interactions
Shixian Lv et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer
Xiangsheng Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
Clinical Trials Investigating Immune Checkpoint Blockade in Glioblastoma
Russell Maxwell et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2017)
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi et al.
NATURE REVIEWS IMMUNOLOGY (2017)
The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
Nicolas J. Llosa et al.
CANCER DISCOVERY (2015)
Transcription Factor Smad-Independent T Helper 17 Cell Induction by Transforming-Growth Factor-β Is Mediated by Suppression of Eomesodermin
Kenji Ichiyama et al.
IMMUNITY (2011)
Doxorubicin-induccd cardiomyopathy from the cardiotoxic mechanisms to management
Genzou Takemura et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2007)
A detailed examination of boronic acid-diol complexation
G Springsteen et al.
TETRAHEDRON (2002)
Share Paper
